Back to Trades
Total Value
$0
Filing Date
Jul 23, 2026
1 transaction
Trade Summary
On Jul 21, 2026, Tatsis Ourania, EVP, Chief Reg. & Quality Off., reported $0 of VERTEX PHARMACEUTICALS INC / MA (VRTX) across 1 transaction. The filing covers Common Stock and reflects balanced net activity of $0. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- VERTEX PHARMACEUTICALS INC / MA
- Ticker Symbol
- VRTX
- CIK
- 0000875320
Insider Information
- Name
- Tatsis Ourania
- Role
- EVP, Chief Reg. & Quality Off.
- Location
- BOSTON, MA
Filing Details
- Filing Date
- Jul 23, 2026
- Transaction Date
- Jul 21, 2026
- Accession Number
- 0000875320-26-000253
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jul 21, 2026 | Common Stock | 8,251 | — | Grant/Award | — |
Want live alerts when Tatsis Ourania trades again?
Download Insider Trades to track VRTX, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Restricted stock unit award that vests on 03/31/2030.